ANDERSON KAREN M. (Chief People Officer) sold 10.6% of their position (6.47K shares) of CENTESSA PHARMACEUTICALS PLC on the open market
Open‑market sale worth $109.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2025ACC: 0001847903-25-000026
Officer· Chief People Officer
Since Mar 2026
+102.80K
Net shares
Net buyer
$290.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
120K acquired · 17.20K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−10.73K
Price / share
$16.92
Trade value
$181.59K
% of position
15.0%
2/1/2025
71.53K→60.79K
Ordinary Shares
Direct
Shares
−6.47K
Price / share
$16.86
Trade value
$109.12K
% of position
10.6%
2/3/2025
60.79K→54.32K
Total
Net shares
−17.20K
Net value
-$290.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/1/2025 | F · Tax Withholding | −10.73K | $16.92 | $181.59K | 15.0% | 71.53K | 60.79K |
| Ordinary Shares Direct | 2/3/2025 | S · Sale | −6.47K | $16.86 | $109.12K | 10.6% | 60.79K | 54.32K |
| Total | −17.20K | -$290.71K | ||||||
Derivative Transactions1
Share Option (right to buy)
Direct
Converts to
Ordinary Shares
120K shares
Shares
+120K
Strike price
16.90
Held after
120K
Exercisable
—
2/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (right to buy) Direct | Ordinary Shares120K shares | 2/3/2025 | A · Award | +120K | 16.90 | — | 120K |